Ganglioside Composition of Normal and Mutant Mouse Embryos

Publisher Website
Google Scholar
Abstract
The enrichment of gangliosides in neuronal membranes suggests that they play an important role in CNS development. We recently found a marked tetrasialoganglioside deficiency in tw1/tw1 mutant mouse embryos at embryonic day (E)‐11. The recessive tw1/tw1 mutants die at embryonic ages E‐9 to E‐18 from failed neural differentiation in the ventral portion of the neural tube. In the present study, we examined the composition and distribution of gangliosides in tw1/tw1 mutant mouse embryos at E‐12. The total ganglioside sialic acid concentration was significantly lower in the mutants than in normal (+/‐) embryos. The mutants also expressed significant deficiencies of gangliosides in the “b′’ metabolic pathway (GD3, GD1b, GT1b, and GQ1b) and elevations in levels of gangliosides in the “a′’ metabolic pathway (GM3, GM2, GM1, and GD1a). These findings suggest that the mutants have a partial deficiency in the activity of a specific sialyltransferase in the b pathway. Regional ganglioside distribution was also studied in E‐12 normal mouse embryos. The ganglioside composition in heads and bodies was similar to each other and to whole embryos. Total ganglioside concentration and the distribution of b pathway gangliosides were significantly higher in neural tube regions than in nonneural tube regions. These findings suggest that b pathway gangliosides accumulate in differentiating neural cells and that the deficiency of these gangliosides in the tw1/tw1 mutants is closely associated with failed neural differentiation.